VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 74 filers reported holding VERVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,251 | -33.0% | 49,491 | -5.3% | 0.00% | 0.0% |
| Q2 2023 | $979,406 | +44.1% | 52,235 | +10.8% | 0.00% | 0.0% |
| Q1 2023 | $679,903 | -25.7% | 47,150 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $915,429 | -41.6% | 47,309 | +3.6% | 0.00% | -66.7% |
| Q3 2022 | $1,568,000 | +219.3% | 45,662 | +42.2% | 0.00% | +200.0% |
| Q2 2022 | $491,000 | -28.2% | 32,122 | +7.1% | 0.00% | 0.0% |
| Q1 2022 | $684,000 | -18.4% | 29,992 | +32.0% | 0.00% | 0.0% |
| Q4 2021 | $838,000 | +109.0% | 22,723 | +166.1% | 0.00% | 0.0% |
| Q3 2021 | $401,000 | – | 8,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |